Immupeutics Medicine (Biotechnology) — Funding, Investors & Signals 2026

Immupeutics Medicine

Advancing the future of tumor treatment through innovative research and application in immunotherapy.

Founded 2018 11-50 employees Seed Total: $100.00M Biotechnology

Immupeutics Medical Technology Co., Ltd. is a **biomedical research company** founded in **2018** with a focus on advancing the future of tumor treatment through innovative research and application in immunotherapy. The company's slogan, "Advancing the future of tumor treatment through innovative research and application in immunotherapy," reflects its commitment to pioneering advancements in cancer treatment. Immupeutics primarily engages in the research and application of immunotherapy for various types of tumors, positioning itself at the forefront of the biotechnology industry. With its latest milestone being the **Seed Round investment** received on **14 November 2023**, Immupeutics Medicine has attracted substantial support from notable investors, including **Alwin Capital, Shanghai Junshi Biosciences, and Shunxi Fund**. This demonstrates not only the confidence of investors in the company's vision but also the potential perceived in the efficacy of its research and the application of immunotherapy in tumor treatment. The company's focus on a cutting-edge and fast-evolving field such as immunotherapy, combined with the timing of its latest investment round, suggests a strong strategic approach towards capitalizing on the increasing demand for innovative cancer treatment solutions. Immupeutics Medicine's ability to attract significant investment in the relatively short period since its founding underscores its potential for future growth and influence within the biotechnology industry.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed Round	••••••	4	•••• ••••	14 Nov 2023
Seed Round	••••••	4		29 Sep 2021
Venture Round	••••••	1		01 Nov 2018

Funding Stage

Amount

Investors

Lead Investors

Date

Seed Round

••••••

•••• ••••

14 Nov 2023

Seed Round

••••••

29 Sep 2021

Venture Round

••••••

01 Nov 2018

FAQ About Immupeutics Medicine

Advancing the future of tumor treatment through innovative research and application in immunotherapy.

Immupeutics Medicine was founded in 2018.

Immupeutics Medicine operates in the following industries: Biotechnology.

Immupeutics Medicine has approximately 11-50 employees.

Immupeutics Medicine has completed 3 funding rounds, raising a total of $100.00M. The latest funding stage is Seed.

Top alternatives and competitors to Immupeutics Medicine include Auristone Pte Ltd, Huasaiboman Medical Cell Biology, KaliVir Immunotherapeutics, ImmuniT Research, ImmunoCellular Therapeutics Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Immupeutics Medicine and Auristone Pte Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Immupeutics Medicine

General Information

Track Immupeutics Medicine

Discover More

About Immupeutics Medicine

Funding Rounds & Investors (3)

Immupeutics Medicine Alternatives & Competitors

FAQ About Immupeutics Medicine

Don't just browse. Track.